{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-28",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 14491
    }
  },
  "results": [
    {
      "safetyreportversion": "2",
      "safetyreportid": "10003584",
      "primarysourcecountry": "CA",
      "occurcountry": "CA",
      "transmissiondateformat": "102",
      "transmissiondate": "20141212",
      "reporttype": "2",
      "serious": "2",
      "receivedateformat": "102",
      "receivedate": "20140312",
      "receiptdateformat": "102",
      "receiptdate": "20140509",
      "fulfillexpeditecriteria": "1",
      "companynumb": "PHHY2014CA029407",
      "duplicate": "1",
      "reportduplicate": {
        "duplicatesource": "NOVARTIS",
        "duplicatenumb": "PHHY2014CA029407"
      },
      "primarysource": {
        "reportercountry": "CA",
        "qualification": "1"
      },
      "sender": {
        "sendertype": "2",
        "senderorganization": "FDA-Public Use"
      },
      "receiver": {
        "receivertype": "6",
        "receiverorganization": "FDA"
      },
      "patient": {
        "patientweight": "57",
        "patientsex": "2",
        "reaction": [
          {
            "reactionmeddraversionpt": "17.0",
            "reactionmeddrapt": "Bone density decreased",
            "reactionoutcome": "6"
          }
        ],
        "drug": [
          {
            "drugcharacterization": "1",
            "medicinalproduct": "ACLASTA/ZOLEDRONATE",
            "drugauthorizationnumb": "021817",
            "drugstructuredosagenumb": "5",
            "drugstructuredosageunit": "003",
            "drugdosagetext": "5 MG/100ML",
            "drugadministrationroute": "042",
            "drugindication": "OSTEOPOROSIS",
            "drugstartdateformat": "102",
            "drugstartdate": "20100329",
            "actiondrug": "4"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "DIDROCAL",
            "drugstructuredosagenumb": "400",
            "drugstructuredosageunit": "003",
            "drugdosagetext": "400 MG, DAILY",
            "actiondrug": "5",
            "drugrecurreadministration": "3"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "EVISTA",
            "drugstructuredosagenumb": "670",
            "drugstructuredosageunit": "003",
            "drugdosagetext": "670 MG, DAILY",
            "actiondrug": "5",
            "drugrecurreadministration": "3",
            "openfda": {
              "application_number": [
                "NDA020815"
              ],
              "brand_name": [
                "EVISTA"
              ],
              "generic_name": [
                "RALOXIFENE HYDROCHLORIDE"
              ],
              "manufacturer_name": [
                "Eli Lilly and Company"
              ],
              "product_ndc": [
                "0002-4184"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "RALOXIFENE HYDROCHLORIDE"
              ],
              "rxcui": [
                "1490065",
                "1490067"
              ],
              "spl_id": [
                "d46edd04-2907-438c-9e1f-b94b5509c0fd"
              ],
              "spl_set_id": [
                "fcaaa6dc-74e8-4fb8-800c-5574bf0f8de9"
              ],
              "package_ndc": [
                "0002-4184-30"
              ],
              "unii": [
                "4F86W47BR6"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "FORTEO",
            "drugstructuredosagenumb": "20",
            "drugstructuredosageunit": "003",
            "drugdosagetext": "20 MG, DAILY",
            "actiondrug": "5",
            "drugrecurreadministration": "3",
            "openfda": {
              "application_number": [
                "NDA021318"
              ],
              "brand_name": [
                "FORTEO"
              ],
              "generic_name": [
                "TERIPARATIDE"
              ],
              "manufacturer_name": [
                "Eli Lilly and Company"
              ],
              "product_ndc": [
                "0002-8400",
                "0002-9678"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "SUBCUTANEOUS"
              ],
              "substance_name": [
                "TERIPARATIDE"
              ],
              "rxcui": [
                "1435115",
                "1435117"
              ],
              "spl_id": [
                "31aeb334-c6d1-4018-af85-17ef69850001"
              ],
              "spl_set_id": [
                "aae667c5-381f-4f92-93df-2ed6158d07b0"
              ],
              "package_ndc": [
                "0002-8400-01",
                "0002-9678-01"
              ],
              "nui": [
                "M0015931",
                "N0000180852"
              ],
              "pharm_class_cs": [
                "Parathyroid Hormone [CS]"
              ],
              "pharm_class_epc": [
                "Parathyroid Hormone Analog [EPC]"
              ],
              "unii": [
                "10T9CSU89I"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "MIACALCIN",
            "drugdosagetext": "200 UI, DAILY",
            "drugdosageform": "NASAL SPRAY",
            "actiondrug": "5",
            "drugrecurreadministration": "3",
            "openfda": {
              "application_number": [
                "NDA017808"
              ],
              "brand_name": [
                "MIACALCIN"
              ],
              "generic_name": [
                "CALCITONIN SALMON"
              ],
              "manufacturer_name": [
                "Mylan Institutional LLC"
              ],
              "product_ndc": [
                "67457-675",
                "72078-038",
                "72078-039"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "INTRAMUSCULAR",
                "SUBCUTANEOUS"
              ],
              "substance_name": [
                "CALCITONIN SALMON"
              ],
              "rxcui": [
                "213570",
                "308866"
              ],
              "spl_id": [
                "ebb1716e-a4f1-42c4-82ac-ba5c062cfba0",
                "d54536c6-69ce-48d4-b2fc-6019cb9d09b6",
                "2edfaa42-e7db-451c-9268-ef3bbead7263"
              ],
              "spl_set_id": [
                "89cd4f46-b88a-4c10-b25c-47352280dc4e",
                "753ecc6a-07be-4fc6-9032-cc6ad116a662",
                "26caf31f-7f7c-48a8-a1ac-35d2ceefda2b"
              ],
              "package_ndc": [
                "67457-675-02",
                "72078-038-02",
                "72078-039-02"
              ],
              "nui": [
                "M0003145",
                "N0000175942"
              ],
              "pharm_class_cs": [
                "Calcitonin [CS]"
              ],
              "pharm_class_epc": [
                "Calcitonin [EPC]"
              ],
              "unii": [
                "7SFC6U2VI5"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "VITAMIN D",
            "drugseparatedosagenumb": "2",
            "drugintervaldosageunitnumb": "1",
            "drugintervaldosagedefinition": "804",
            "drugdosagetext": "400 UI, BID",
            "drugstartdateformat": "102",
            "drugstartdate": "20100311",
            "actiondrug": "5",
            "drugrecurreadministration": "3",
            "openfda": {
              "application_number": [
                "ANDA090455"
              ],
              "brand_name": [
                "VITAMIN D"
              ],
              "generic_name": [
                "ERGOCALCIFEROL"
              ],
              "manufacturer_name": [
                "Strides Pharma Science Limited"
              ],
              "product_ndc": [
                "64380-737"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "ERGOCALCIFEROL"
              ],
              "rxcui": [
                "1367410"
              ],
              "spl_id": [
                "1cc589f7-cd6d-40a6-8fce-c965e8945eae"
              ],
              "spl_set_id": [
                "2c4c0a36-12cf-444d-9d57-de983eef4d36"
              ],
              "package_ndc": [
                "64380-737-06",
                "64380-737-25"
              ],
              "nui": [
                "M0007651",
                "N0000175909"
              ],
              "pharm_class_cs": [
                "Ergocalciferols [CS]"
              ],
              "pharm_class_epc": [
                "Provitamin D2 Compound [EPC]"
              ],
              "unii": [
                "VS041H42XC"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "CALCIUM",
            "drugseparatedosagenumb": "2",
            "drugintervaldosageunitnumb": "1",
            "drugintervaldosagedefinition": "804",
            "drugdosagetext": "500 UKN, BID",
            "drugstartdateformat": "102",
            "drugstartdate": "20100311",
            "actiondrug": "5",
            "drugrecurreadministration": "3",
            "openfda": {
              "brand_name": [
                "7030 CALCIUM PREMIUM",
                "AG-X",
                "7030 CALCIUM GOLD"
              ],
              "generic_name": [
                "CALCIUM"
              ],
              "manufacturer_name": [
                "Apexel Co., Ltd",
                "APEXEL CO., LTD."
              ],
              "product_ndc": [
                "55259-1112",
                "55259-0007",
                "55259-0001"
              ],
              "product_type": [
                "HUMAN OTC DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "CALCIUM"
              ],
              "spl_id": [
                "0fa8135f-89c9-41a2-e063-6294a90a403d",
                "11cc283a-fe2c-f101-e063-6294a90ad2d4",
                "11cc310a-d82e-be44-e063-6394a90a227c"
              ],
              "spl_set_id": [
                "bdc7c833-daf7-48f9-e053-2995a90ad88e",
                "bdee5e24-645b-7fa0-e053-2995a90a7d25",
                "bdc7c088-83e3-20ce-e053-2995a90abd2f"
              ],
              "package_ndc": [
                "55259-1112-1",
                "55259-0007-1",
                "55259-0001-1"
              ],
              "nui": [
                "M0003153",
                "N0000175901"
              ],
              "pharm_class_cs": [
                "Calcium [CS]"
              ],
              "pharm_class_epc": [
                "Calcium [EPC]"
              ],
              "unii": [
                "SY7Q814VUP"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "BISPHOSPHONATES",
            "drugdosagetext": "UNK UKN, UNK",
            "drugadministrationroute": "048",
            "actiondrug": "5",
            "drugrecurreadministration": "3"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "HORMONES NOS",
            "actiondrug": "5"
          }
        ]
      }
    }
  ]
}